HPTN089: An HIV Prevention Study

Join Charlie

The HPTN089 study tests the tolerability, safety, and the immune system’s response to combinations of experimental HIV antibodies.

  • We are looking for 18–50 year olds
  • HIV uninfected individuals
  • Participation in this study will range from 12–16 months
  • Participants will be compensated $1,000 for their time

For more information, call 617-927-6450 or email bethechange@fenwayhealth.org

To find out if you are eligible, click here.

Translate »